Three-year interim results of overall and progression-free survival in a cohort of patients with prostate cancer (GESCAP group).
Cózar, J M
Three-year interim results of overall and progression-free survival in a cohort of patients with prostate cancer (GESCAP group). [electronic resource] - Actas urologicas espanolas - 4-11 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study
2173-5786
10.1016/j.acuro.2018.03.004 doi
Adenocarcinoma--epidemiology
Aged
Combined Modality Therapy
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Progression-Free Survival
Proportional Hazards Models
Prospective Studies
Prostatic Neoplasms--epidemiology
Prostatic Neoplasms, Castration-Resistant--epidemiology
Risk
Spain--epidemiology
Treatment Outcome
Three-year interim results of overall and progression-free survival in a cohort of patients with prostate cancer (GESCAP group). [electronic resource] - Actas urologicas espanolas - 4-11 p. digital
Publication Type: Journal Article; Multicenter Study; Observational Study
2173-5786
10.1016/j.acuro.2018.03.004 doi
Adenocarcinoma--epidemiology
Aged
Combined Modality Therapy
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Progression-Free Survival
Proportional Hazards Models
Prospective Studies
Prostatic Neoplasms--epidemiology
Prostatic Neoplasms, Castration-Resistant--epidemiology
Risk
Spain--epidemiology
Treatment Outcome